Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Psychiatry|May 25, 2010
The neurobiology of the switch process in bipolar disorder: a reviewGiacomo Salvadore, Jorge A Quiroz, Rodrigo Machado-Vieira, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 18, 2010
A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophreniaHenry A Nasrallah, Srihari Gopal, Cristiana Gassmann-Mayer, et al.
JAMA Psychiatry|June 16, 2016
Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical TrialJorge A Quiroz, Paul Tamburri, Dennis Deptula, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 2, 2006
The underlying neurobiology of bipolar disorderHusseini K Manji, Jorge A Quiroz, Jennifer L Payne, et al.
Journal of Medical Engineering & Technology|July 16, 2019
Validation of an ambient measurement system (AMS) for physical activities in a paediatric populationJonathan S Varsanik, Zebadiah M Kimmel, Genevieve A Laforet, et al.
Biological Psychiatry|April 23, 2003
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depressionHusseini K Manji, Jorge A Quiroz, Jonathan Sporn, et al.
Biological Psychiatry|June 29, 2004
Pramipexole for bipolar II depression: a placebo-controlled proof of concept studyCarlos A Zarate, Jennifer L Payne, Jaskaran Singh, et al.
Biological Psychiatry|February 12, 2005
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depressionCarlos A Zarate, Jorge A Quiroz, Jaskaran B Singh, et al.
The American Journal of Psychiatry|January 5, 2006
A double-blind, placebo-controlled study of memantine in the treatment of major depressionCarlos A Zarate, Jaskaran B Singh, Jorge A Quiroz, et al.
Pageof 3